JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on September 9, 2003; DOI: 10.1124/jpet.103.052688


0022-3565/03/3072-640-650$20.00
JPET 307:640-650, 2003
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correction
Right arrow An erratum has been published
Right arrow All Versions of this Article:
jpet.103.052688v1
307/2/640    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Carraway, R. E.
Right arrow Articles by Cochrane, D. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Carraway, R. E.
Right arrow Articles by Cochrane, D. E.

CELLULAR AND MOLECULAR

Ca2+ Channel Blockers Enhance Neurotensin (NT) Binding and Inhibit NT-Induced Inositol Phosphate Formation in Prostate Cancer PC3 Cells

Robert E. Carraway, Xianyong Gui, and David E. Cochrane

Department of Physiology, University of Massachusetts Medical School, Worcester, Massachusetts (R.E.C., X.G.); and Department of Biology, Tufts University, Medford, Massachusetts (D.E.C.)

Neurotensin (NT) stimulates Ca2+ release and Ca2+ influx in many cells. Its contractile effects in smooth muscle are inhibited by removal of Ca2+ and by Ca2+ channel blockers (CCBs). To better understand NT signaling in prostate cancer PC3 cells, blockers of voltage-gated and store-operated Ca2+ channels (VGCC and SOCC) were tested for effects on NT-binding and signaling. Eight chemical types of agents, including VGCC-blocker nifedipine and SOCC-blocker SKF-96365 (1-[{beta}-[3-(4-methoxyphenyl)-propoxy]-4-methoxyphenyl]-1H-imidazole), enhanced cellular NT binding up to 3-fold, while inhibiting (by {cong}70%) NT-induced inositol phosphate (IP) formation. The ability to enhance NT binding correlated with the ability to inhibit NT-induced IP formation, and both effects were relatively specific for NT. Although cellular binding for {beta}2-adrenergic, V1a-vasopressin, and epidermal growth factor receptors was not enhanced by these drugs, bombesin receptor binding was increased {cong}19% and bombesin-induced IP formation was inhibited {cong}15%. One difference was that the effect on NT binding was Ca2+-independent, whereas the effect on IP formation was Ca2+-dependent (in part). The Ca2+-dependent part of the IP response seemed to involve SOCC-mediated Ca2+ influx to activate phospholipase C (PLC){delta}, while the Ca2+-independent part probably involved PLC{beta}. Photoaffinity labeling of the NT receptor NTR1 was enhanced in CCB-treated cells. NTR1 affinity was increased but NTR1 number and internalization were unchanged. Since CCBs did not alter NT binding to isolated cell membranes, the effects in live cells were indirect. These results suggest that CCBs exert two effects: 1) they inhibit NT-induced IP formation, perhaps by preventing Ca2+ influx-dependent activation of PLC{delta}; and 2) they enhance NTR1 affinity by an unexplained Ca2+-independent mechanism.


Received April 4, 2003; accepted July 8, 2003.

Address correspondence to: Dr. Robert E. Carraway, Department of Physiology, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, MA 01655. E-mail: robert.carraway{at}umassmed.edu




This article has been cited by other articles:


Home page
J. Neurosci.Home page
K. A. Petrie, D. Schmidt, M. Bubser, J. Fadel, R. E. Carraway, and A. Y. Deutch
Neurotensin Activates GABAergic Interneurons in the Prefrontal Cortex
J. Neurosci., February 16, 2005; 25(7): 1629 - 1636.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. E. Carraway, S. Hassan, and D. E. Cochrane
Polyphenolic Antioxidants Mimic the Effects of 1,4-Dihydropyridines on Neurotensin Receptor Function in PC3 Cells
J. Pharmacol. Exp. Ther., April 1, 2004; 309(1): 92 - 101.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2003 by the American Society for Pharmacology and Experimental Therapeutics.